Rosemont Pharmaceuticals

Global pharmaceutical company headquartered in Leeds with ~60 years of experience developing, manufacturing and supplying oral liquid medicines for patients with swallowing difficulties. Portfolio of 130+ oral liquid medicines (70 licensed), commanding 50%+ of the UK market and sole UK supplier of 27 unique molecules. Produces 4M+ bottles per year. Backed by Inflexion Private Equity.